Nanjing Hicin Pharmaceutical Co., Ltd. (300584) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nanjing Hicin Pharmaceutical Co., Ltd.

Why is Nanjing Hicin Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 4.33%

The company has been able to generate a Return on Capital Employed (avg) of 4.33% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -7.46% and Operating profit at -11.85% over the last 5 years

Flat results in Mar 25

INTEREST(HY) At CNY 3.94 MM has Grown at 5.71%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.32%
OPERATING PROFIT(Q) Lowest at CNY 17.75 MM

With ROE of 4.26%, it has a very expensive valuation with a 3.51 Price to Book Value

Over the past year, while the stock has generated a return of 134.15%, its profits have risen by 6.6% ; the PEG ratio of the company is 12.5
At the current price, the company has a high dividend yield of 0.2

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Hicin Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nanjing Hicin Pharmaceutical Co., Ltd.

130.55%

3.14

80.27%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-7.46%

EBIT Growth (5y)

-11.85%

EBIT to Interest (avg)

5.66

Debt to EBITDA (avg)

1.66

Net Debt to Equity (avg)

0.25

Sales to Capital Employed (avg)

0.39

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

29.83%

Pledged Shares

Institutional Holding

ROCE (avg)

4.33%

ROE (avg)

4.12%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.51

EV to EBIT

74.06

EV to EBITDA

36.01

EV to Capital Employed

3.04

EV to Sales

6.89

PEG Ratio

12.50

Dividend Yield

0.18%

ROCE (Latest)

4.11%

ROE (Latest)

4.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 98.43 MM

RAW MATERIAL COST(Y)

Fallen by -17.23% (YoY

PRE-TAX PROFIT(Q)

At CNY 16.35 MM has Grown at 59.41%

NET PROFIT(Q)

Highest at CNY 15.04 MM

EPS(Q)

Highest at CNY 0.13

-6What is not working for the Company

INTEREST(HY)

At CNY 3.94 MM has Grown at 5.71%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.32%

OPERATING PROFIT(Q)

Lowest at CNY 17.75 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 12.73 %

Here's what is working for Nanjing Hicin Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 98.43 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY 16.35 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 16.35 MM has Grown at 59.41%

over average net sales of the previous four periods of CNY 10.26 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 15.04 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.13

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -17.23% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Hicin Pharmaceutical Co., Ltd.

Interest

At CNY 3.94 MM has Grown at 5.71%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 1.32% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Profit

Lowest at CNY 17.75 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 12.73 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales